A Perspective on Benzene Leukemogenesis

References

• Santesson C. G. Uber chronische Vergiftung mit Steinkohlen-teerbenzin, vier Todesfalle. Arch. Hyg. Bed. 1897; 31: 336
   Google Scholar
• Selling L. A preliminary report of some cases of purpura haemorrhagica due to benzol poisoning. Bull. Johns Hopkins Hosp. 1910; 21: 33
   Google Scholar
• Selling L. Benzol as a leukotoxin. Studies on degeneration regeneration of blood and hematopoietic organs. Johns Hopkins Hosp. Rep. 1916; 17: 83
   Google Scholar
• Synder R., Kocsis J. J. Current concepts of chronic benzene toxicity. Crit. Rev. Toxicol. 1975; 3: 265
   Google Scholar
• Synder R., Longacre S. L., Witmer C. M., Kocsis J. J. Biochemical toxicity of benzene. Reviews in Biochemical Toxicology, E. Hodgson, J. R. Bend, R. ML Philpot. Elsevier, New York 1981; Vol. 3: 123
   Google Scholar
• Synder R. The benzene problem in historical perspective. Fundam. Appl. Toxicol. 1984; 4: 692
   PubMedGoogle Scholar
• Kalf G. F. Recent advances in the metabolism and toxicity of benzene. Crit. Rev. Toxicol. 1987; 18: 141
   PubMed Web of Science ®Google Scholar
• Kalf G. F., Post G., Snyder R. Solvent toxicology: recent advances in the toxicology of benzene, the glycol ethers, and carbon tetrachloride. Annu. Rev. Pharmacol. Toxicol. 1987; 27: 399
   PubMed Web of Science ®Google Scholar
• Le Noir C. Sur un cas de purpura attributé a l'intoxication par le benzène. Bull. Mem. Soc. Med. Hosp. Paris 1987; 14: 1251
   Google Scholar
• Delore P., Borgomano C. Leucemie aigue au cours d'intoxication benzenique. Sur l'origine toxique de certaines leucemies aigues et leur relations avec les anemies graves. J. Med. Lyon. 1928; 9: 227
   Google Scholar
• Mallory T. B., Gall E. A., Brickley W. J. Chronic exposure to benzene (benzol). III. The pathologic results. J. Ind. Hyg. Toxicol. 1939; 21: 355
   Google Scholar
• Lignac G. O. E. Benzene induced leukemia in humans and white mice. Klin. Wochenschr. 1932; 12: 109
   Google Scholar
• Uyeki E. M., Askar A. E., Shoeman D. W., Bisel T. U. Acute toxicity of benzene inhalation to hemopoietic precursor cells. Toxicol. Appl. Pharmacol. 1977; 40: 49
   PubMed Web of Science ®Google Scholar
• Gill D., Jenkins V., Kemper R., Ellis S. The importance of pluripotent stem cells in benzene toxicity. Toxicology 1980; 16: 163
   PubMed Web of Science ®Google Scholar
• Green J. D., Snyder C. A., Lobue J., Goldstein B. D., Albert R. E. Acute and chronic dose/response effects of inhaled benzene on multipotential hemopoietic stem, CFU-S and granulocyte/macrophage progenitor, GM-CFU-C cells in CD-1 mice. Toxicol. Appl. Pharmacol. 1981; 58: 492
   PubMed Web of Science ®Google Scholar
• Harigaya K., Miller M. E., Cronkite E. P., Drew R. T. The detection ofin vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures. Toxicol. Appl. Pharmacol. 1981; 60: 346
   PubMed Web of Science ®Google Scholar
• Toft K., Olofsson T., Tunek A., Berlin M. Toxic effects on mouse bone marrow caused by inhalation of benzene. Arch. Toxicol. 1982; 51: 295
   Web of Science ®Google Scholar
• Baarson K., Snyder C. A., Albert R. E. Repeated exposures of C57B16 mice to 10 ppm inhaled benzene markedly depressed erythropoietic colony formation. Toxicol. Lett. 1984; 20: 337
   PubMed Web of Science ®Google Scholar
• Seidel H. J., Barthel E., Zinser D. The hematopoietic stem cell compartments in mice during and after long term inhalation of three doses of benzene. Exp. Hematol. 1989; 17: 300
   PubMed Web of Science ®Google Scholar
• Anon. Benzene, 1ARC Monogr. Eval. Carcinog. Risks Hum. 1982; 29: 93
   Google Scholar
• Snyder C. A. Benzene, in Ethel Browning's Toxicity and Metabolism of Industrial Solvents. Hydrocarbons, 2nd ed., R. Synder. Elsevier, Amsterdam 1986; Vol. 1: 3
   Google Scholar
• Bagby G. C., Jr. The concept of preleukemia: clinical and laboratory studies. Crit. Rev. Oncol./Hematol. 1986; 4: 203
   PubMed Web of Science ®Google Scholar
• Tricot G. J. K. The myelodysplastic syndromes. Hematology, Basic Principles and Practice, R. Hoffman, E. J. Benz, Jr., S. J. Shattil, B. Furie, H. J. Cohen. Churchill Livingstone, New York 1991; 805
   Google Scholar
• Galton D. A. The myelodysplastic syndromes. Scand. J. Haematol. 1986; 36: 11
   PubMedGoogle Scholar
• Janssen J. W. G., Buschle M., Layton M., Drexler H. G., Lyons J., van den Burghe H., Heimpel H., Kubanek B., Kleihauer E., Mufti G. J., Bartram C. R. Clonal analysis of myelodysplastic syndrome. Evidence of multipotent stem cell origin. Blood 1989; 73: 248
   PubMed Web of Science ®Google Scholar
• Tefferi A., Thibodeau S. N., Solberg L. S. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990; 52: 285
   Google Scholar
• Irons R. D. Studies on the mechanisms of chemically induced leukemia/lymphoma. Chem. Ind. Inst. Activities 1988; 8: 1
   Google Scholar
• Vigliani E., Forni A. Benzene and leukemia. Environ. Res. 1976; 11: 122
   PubMed Web of Science ®Google Scholar
• Aksoy M. Benzene hematotoxicity. Benzene Carcinogenicity, M. Aksoy. CRC Press, Boca Raton, FL 1988; 59
   Google Scholar
• Goldwater L. J. Disturbances in the blood following exposure to benzol. J. Lab. Clin. Med. 1940; 26: 957
   Google Scholar
• Hamilton-Patterson J. L., Browning E. Toxic effects in women exposed to industrial rubber solutions. Br. Med. J. 1944; 4340: 11
   Google Scholar
• Helmer K. J. Accumulated cases of chronic benzene poisoning in the rubber industry. Acta Med. Scand. 1944; 118: 254
   Google Scholar
• Savilahti M. More than 100 cases of benzene intoxication in a shoe factory. Observations on hematological symptoms and course of the process in one year. Arch. Gewerbepath. Gewerbehyg. 1956; 15: 147
   PubMedGoogle Scholar
• Aksoy M., Dincol K., Akgun T., Erdem S., Dincol G. Haematological effects of chronic benzene poisoning in 217 workers. Br. J. Ind. Med. 1971; 28: 296
   PubMedGoogle Scholar
• Aksoy M., Dincol K., Erdem S., Akgun T., Dincol G. Details of blood changes in 32 patients with pancytopenia associated with long-term exposure to benzene. Br. J. Industr. Med. 1972; 29: 56
   PubMedGoogle Scholar
• Aksoy M., Erdem S., Erdogan G., Dincol G. Combination of genetic factors and chronic exposure to benzene in the aetiology of leukaemia. Hum. Hered. 1976; 26: 149
   PubMed Web of Science ®Google Scholar
• Aksoy M. Benzene and leukemia. Lancet 1978; i: 441
   Google Scholar
• Aksoy M., Erdem S. Follow-up study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic benzene exposure. Blood 1978; 52: 285
   PubMed Web of Science ®Google Scholar
• Aksoy M. Malignancies due to occupational exposure to benzene. Am. J. Ind. Med. 1985; 7: 395
   PubMed Web of Science ®Google Scholar
• Yin S. N., Li G. L., Tain F. D., Fu N. I., Jin C., Chen Y. J., Luo S. J., Ye P. Z., Zhang J. Z., Wang G. C., Zhang X. C., Wu H. N., Zhong Q. C. Leukaemia in benzene workers, a retrospective cohort study. Br. J. Ind. Med. 1987; 44: 124
   PubMedGoogle Scholar
• Yin S.-N., Li Q., Tian F., Du C., Jin C. Occupational exposure to benzene in China. Br. J. Ind. Med. 1987; 44: 192
   PubMedGoogle Scholar
• Austin H., Delzell E., Cole P. Benzene and leukemia. A review of the literature and a risk assessment. Am. J. Epidemiol. 1988; 127: 419
   PubMed Web of Science ®Google Scholar
• Girard R., Revol L. Frequency of benzene exposure in the course of serious blood diseases. Nouv. Rev. Fr. d'Hemat. 1970; 10: 477
   PubMedGoogle Scholar
• Ishimaru T., Okada H., Tomiyasu T., Tschuioto T., Hoshino T., Ichmaru M. Occupational factors in the epidemiology of leukemia in Hiroshima and Nagasaki. Am. J. Epidemiol. 1971; 93: 157
   PubMed Web of Science ®Google Scholar
• Thorpe J. J. Epidemiological survey of leukemia in persons potentially exposed to benzene. J. Occup. Med. 1974; 17: 375
   Google Scholar
• Infante P., Rinsky R., Wagoner J., Young R. Leukemia in benzene workers. Lancet 1977; ii: 76
   Google Scholar
• Rinsky R. A., Smith A. B., Hornung R., Filloon T. G., Young R. J., Okun A. K., Landrigan P. J. Benzene and leukemia, an epidemiological risk assessment. N. Engl. J. Med. 1987; 316: 1044
   PubMed Web of Science ®Google Scholar
• Rinsky R. A., Young R. J., Smith A. Leukemia in benzene workers. Am. J. Ind. Med. 1981; 2: 217
   PubMedGoogle Scholar
• Ott M. G., Townsend J. C., Fishbeck W. A., Langner R. A. Mortality among individuals occupationally exposed to benzene. Arch. Environ. Health 1978; 33: 3
   PubMed Web of Science ®Google Scholar
• Bond G. G., McLaren E. A., Baldwin C. L., Cook R. R. An update of mortality among chemical workers exposed to benzene. Br. J. Ind. Med. 1986; 43: 685
   PubMedGoogle Scholar
• Linos A., Kyle R. A., O'Fallon W. M., Kurland L. T. A case control study of occupational exposures and leukemia. Int. J. Epidemiol. 1980; 9: 131
   PubMed Web of Science ®Google Scholar
• Rushton L., Alderson M. R. A case-control study to investigate the association between exposure to benzene and deaths from leukaemia in oil refinery workers. Br. J. Cancer 1981; 43: 77
   PubMed Web of Science ®Google Scholar
• Decouflé P., Blattner W. A., Blair A. Mortality among chemical workers exposed to benzene and other agents. Environ. Res. 1983; 30: 16
   PubMed Web of Science ®Google Scholar
• Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results. Br. J. Ind. Med. 1987; 44: 365
   PubMedGoogle Scholar
• Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br. J. Ind. Med. 1987; 44: 382
   PubMedGoogle Scholar
• Tsai S. P., Wen C. P., Weiss N. S., Wong O., McClellan W. A., Gibson R. L. Retrospective mortality and medical surveillance studies of workers in benzene areas of refineries. J. Occup. Med. 1983; 25: 685
   PubMedGoogle Scholar
• ACGIH. Notice of intended changes: benzene. Appl. Occup. Environ. Hyg. 1990; 7: 453
   Google Scholar
• White M. C., Infante P., Chu K. C. A quantitative estimate of leukemia mortality associated with occupational exposure to benzene. Risk Analysis 1982; 2: 195
   Web of Science ®Google Scholar
• Albert R. E. Carcinogen Assessment Group's final report on population risk to ambient benzene exposures. Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, Research Triangle Park, NC 1979, Publ. No. EPA-450/5–80–004
   Google Scholar
• Crump K. S., Allen B. C. Quantitative estimates of risk of leukemia from occupational exposure to benzene. Occupational Safety and Health Administration. May, 1984, Docket H-059B, Exhibit 152
   Google Scholar
• Rinsky R. A., Hornung R. W., Landrigan P. J. Re: Benzene and leukemia. A review of the literature and a risk assessment. Am. J. Epidemiol. 1989; 129: 1084
   PubMedGoogle Scholar
• Austin H., Delzell E., Cole P. The authors reply. Am. J. Epidemiol. 1989; 129: 1085
   Google Scholar
• Kipen H. M., Cody R. P., Crump K. S., Allen B., Goldstein B. D. Hematologic effects of benzene. A thirty-five year longitudinal study of rubber workers. Toxicol. Ind. Health 1988; 4: 411
   PubMed Web of Science ®Google Scholar
• Kipen H. M., Cody R. P., Goldstein B. D. Use of longitudinal analysis of peripheral blood counts to validate historical reconstruction of benzene exposure. Environ. Health Perspect. 1989; 82: 199
   PubMed Web of Science ®Google Scholar
• Paustenbach D. J., Price P. S., Ollison W., Blank C., Jernigan J. D., Bass R. D., Peterson H. D. Reevaluation of benzene exposure for the pliofilm, rubberworker cohort, 1936–1976. J. Toxicol. Environ. Health 1992; 36: 177
   PubMed Web of Science ®Google Scholar
• Snyder R., Lee E. W., Kocsis J. J., Witmer C. M. Bone marrow depressant and leukemogenic actions of benzene. Life Sci. 1977; 21: 1709
   PubMed Web of Science ®Google Scholar
• Goldstein B. D., Snyder C. A., Laskin S., Bromberg I., Albert R. E., Nelson N. Myelogenous leukemia in rodents inhaling benzene. Toxicol. Lett. 1982; 13: 169
   PubMed Web of Science ®Google Scholar
• Cronkite E., Bullis J., Inoe T., Drew R. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 1984; 75: 358
   PubMed Web of Science ®Google Scholar
• Snyder C. A., Goldstein B. D., Sellakumar A. R., Bromberg I., Laskin S., Albert R. E. The inhalation toxicology of benzene, incidence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57B1/6J mice. Toxicol. Appl. Pharmacol. 1980; 54: 323
   PubMed Web of Science ®Google Scholar
• Farris G. M., Everitt J. I., Irons R., Popp J. A. Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol. 1993; 20: 503
   PubMedGoogle Scholar
• Maltoni C., Scarnato C. First experimental demonstration of the carcinogenic effects of benzene. Long-term bioassays on Sprague-Dawley rats by oral administration. Med. Law 1979; 70: 352
   Google Scholar
• Huff J. E., Haseman J. K., DeMarini D. M. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6 C3F1 mice. Environ. Health Perspect. 1989; 82: 125
   PubMed Web of Science ®Google Scholar
• Maltoni C., Conti B., Cotti G. Benzene: a multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Am. J. Ind. Med. 1983; 4: 589
   PubMed Web of Science ®Google Scholar
• Maltoni C., Ciliberti A., Cotti G., Conti B., Belpoggi F. Benzene: an experimental multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect. 1989; 82: 109
   PubMed Web of Science ®Google Scholar
• Porteous J. W., Williams R. T. Studies in detoxication. The isolation of phenol, catechol, quinol and hydroxyquinol from the ethereal sulfate fraction of the urine of rabbits receiving benzene orally. Biochem. J. 1949; 44: 56
   Web of Science ®Google Scholar
• Parke D. V., Williams R. T. Studies in detoxication: 49. The metabolism of benzene containing14C1 benzene. Biochem. J. 1953; 54: 231
   PubMed Web of Science ®Google Scholar
• Henderson R. F., Sabourin P. J., Bechtold W. E., Griffith W. C., Medinsky M. A., Birnbaum L. S., Lucier G. W. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ. Health Perspect. 1989; 82: 9
   PubMed Web of Science ®Google Scholar
• Synder R., Pirozzi-Chatterjee S. Benzene metabolism. Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds, E. Arinc, I. B. Schenckman, E. Hodgson. Plenum Press, New York 1991; 375
   Google Scholar
• Yardley-Jones A., Anderson D., Parke D. V. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br. J. Ind. Med. 1991; 48: 437
   PubMedGoogle Scholar
• Andrews L. S., Sasame H. A., Gillette J. R. 3H-benzene metabolism in rabbit bone marrow. Life Sci. 1979; 25: 567
   PubMed Web of Science ®Google Scholar
• Irons R., Dent J., Baker T., Rickert D. Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. Interact. 1980; 30: 241
   PubMed Web of Science ®Google Scholar
• Sammett D., Lee E. W., Kocsis J. J., Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health 1979; 5: 785
   PubMed Web of Science ®Google Scholar
• Andrews L. S., Lee E. W., Witmer C. M., Kocsis J. J., Snyder R. Effects of toluene on the metabolism, disposition, and hemopoietic toxicity of3H benzene. Biochem. Pharmacol. 1977; 26: 293
   PubMed Web of Science ®Google Scholar
• Smart R. C., Zannoni V. G. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol. 1984; 26: 105
   PubMed Web of Science ®Google Scholar
• Johansson I., Ingelman-Sundberg M. Hydroxyl radical-mediated, cytochrome P-450-dependent metabolic activation of benzene in microsomes and reconstituted enzyme systems from rabbit liver. J. Biol. Chem. 1983; 258: 7311
   PubMed Web of Science ®Google Scholar
• Koop D. R., Laethem C. L., Schnier G. G. Identification of ethanol-inducible P450 isozyme 3a, P45011E1, as a benzene and phenol hydroxylase. Toxicol. Appl. Pharmacol. 1989; 98: 278
   PubMed Web of Science ®Google Scholar
• Chepiga T. A., Yang C. S., Snyder R. Benzene metabolism by two purified, reconstituted rat hepatic mixed function oxidase systems. Biological Reactive Intermediates. IV. Molecular and Cellular Effects and Their Impact on Human Health, C. M. Witmer, R. Snyder, D. J. Jollow, G. F. Kalf, J. J. Kocsis, I. G. Sipes. Plenum Press, New York 1991; 261
   Google Scholar
• Gorsky L. D., Coon M. J. Evaluation of the role of free hydroxyl radicals in the cytochrome P-450 catalyzed oxidation of benzene and cyclohexanol. Drug Metab. Disp. Biol. Fate Chem. 1985; 13: 169
   PubMed Web of Science ®Google Scholar
• Jerina D., Daley J., Witkop B., Zaltzman-Nirenberg P., Udenfriend S. Role of arene oxide-oxepin system in the metabolism of aromatic substrates. I.In vitro conversion of benzene oxide to premercapturic acid and dihydrodiol. Arch. Biochem. Biophys. 1968; 128: 176
   Web of Science ®Google Scholar
• Latriano L., Goldstein B. D., Witz G. Formation of muconaldehyde, an open-ring metabolite of benzene in mouse liver microsomes, a novel pathway for toxic metabolites. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 8356
   PubMed Web of Science ®Google Scholar
• Bolcsak L. E., Nerland D. E. Inhibition of erythropoiesis by benzene and benzene metabolites. Toxicol. Appl. Pharmacol. 1983; 69: 363
   PubMed Web of Science ®Google Scholar
• Snyder R., Dimitriadis E., Guy R., Hu P., Cooper K. R., Bauer H., Witz G., Goldstein B. D. Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 1989; 82: 31
   PubMed Web of Science ®Google Scholar
• Witz G., Rao G. S., Goldstein B. D. Short-term toxicity oftrans, trans-muconaldehyde. Toxicol. Appl. Pharmacol. 1985; 80: 511
   PubMed Web of Science ®Google Scholar
• Twerdok L. E., Trush M. A. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res. Commun. Chem. Pathol. Pharmacol. 1990; 67: 375
   PubMedGoogle Scholar
• Lee E. W., Kocsis J. J., Snyder R. Acute effect of benzene on [59Fe] incorporation into circulating erythrocytes. Toxicol. Appl. Pharmacol. 1974; 27: 431
   PubMed Web of Science ®Google Scholar
• Lee E. W., Kocsis J. J., Snyder R. The use of ferrokinetics in the study of experimental anemia. Environ. Health Perspect. 1981; 39: 29
   PubMed Web of Science ®Google Scholar
• Eastmond D. A., Smith M. T., Irons R. D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987; 91: 85
   PubMed Web of Science ®Google Scholar
• Guy R. L., Dimitriadis E., Hu P., Cooper K. R., Snyder R. Interactive inhibition of erythroid [59Fe] utilization by benzene metabolites in female mice. Chem. Biol. Interact. 1990; 74: 55
   PubMed Web of Science ®Google Scholar
• Guy R. L., Hu P., Witz G., Goldstein B. D. Depression of iron uptake into erythrocytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconaldehyde, and hydroquinone. J. Appl. Toxicol. 1991; 11: 443
   PubMed Web of Science ®Google Scholar
• Barale R., Marrazzini A., Betti C., Vangelisti V., Loprieno N., Barrai I. Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat. Res. 1990; 244: 15
   PubMed Web of Science ®Google Scholar
• Kolanchana P., Subrahmanyam V. V., Meyer K. B., Zhang L., Smith M. T. Benzene and its phenolic metabolites produce oxidative damage in HL-60 cellsin vitro and in bone marrow in vivo. Cancer Res. 1993; 53: 1023
   PubMed Web of Science ®Google Scholar
• Longacre S., Kocsis J. J., Snyder R. Influence of strain differences in mice on the metabolism and toxicity of benzene. Toxicol. Appl. Pharmacol. 1981; 60: 398
   PubMed Web of Science ®Google Scholar
• Neun D. J., Penn A., Snyder C. A. Evidence for strain-specific differences in benzene toxicity as a function of host target cell susceptibility. Arch. Toxicol. 1992; 66: 11
   PubMed Web of Science ®Google Scholar
• Sabourin P. J., Chen B. T., Lucier G., Birnbaum S., Fisher E., Henderson R. F. Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. Toxicol. Appl. Pharmacol. 1987; 87: 325
   PubMed Web of Science ®Google Scholar
• Sabourin P. J., Bechtold W. E., Birnbaum L. S., Lucier G., Henderson R. F. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 1988; 94: 128
   PubMed Web of Science ®Google Scholar
• Snyder R., Orzechowski A., Schrenk D., Schwarz L. R. Benzene metabolism in rat and mouse hepatocytes. Toxicologist 1993; 13: 327
   Google Scholar
• Lutz W., Schlatter C. Mechanism of the carcinogenic action of benzene: irreversible binding to rat liver DNA. Chem. Biol. Interact. 1977; 18: 214
   Web of Science ®Google Scholar
• Snyder R., Lee E. W., Kocsis J. J. Binding of labeled benzene metabolites to mouse liver and bone marrow. Res. Commun. Chem. Pathol. Pharmacol. 1978; 20: 191
   PubMedGoogle Scholar
• Schwartz C. S., Snyder R., Kalf G. F. The inhibition of mitochondrial DNA replicationin vitro by the metabolites of benzene, hydroquinone and p-benzoquinone. Chem. Biol. Interact. 1985; 53: 327
   PubMed Web of Science ®Google Scholar
• Wallin H., Melin P., Schelin C., Jergil B. Evidence that covalent binding of metabolically activated phenol to microsomal proteins is caused by oxidized products of hydroquinone and catechol. Chem. Biol Interact. 1985; 55: 335
   PubMed Web of Science ®Google Scholar
• Schlosser M. J., Kalf G. F. Metabolic activation of hydroquinone by macrophage peroxidase. Chem. Biol Interact. 1989; 72: 191
   PubMed Web of Science ®Google Scholar
• Bhat R. V., Subrahmanyam V. V., Sadler A., Ross D. Bioactivation of catechol in rat and human bone marrow cells. Toxicol. Appl. Pharmacol. 1988; 94: 297
   PubMed Web of Science ®Google Scholar
• Lee E. W., Garner C. D. Effects of benzene on DNA strand breaksin vivo versus benzene metabolite-induced DNA strand breaksin vitro in mouse bone marrow cells. Toxicol. Appl. Pharmacol. 1991; 108: 497
   PubMed Web of Science ®Google Scholar
• Kawanishi S., Inoue S., Kawanishi M. Human DNA damage induced by 1,2,4-benzenetriol, a benzene metabolite. Cancer Res. 1989; 49: 164
   PubMed Web of Science ®Google Scholar
• Sabourin P. J., Muggenburg B. A., Couch R. C., Lefler D., Lucier G., Birnbaum L. S., Henderson R. F. Metabolism of [14C]benzene by cynomolgus monkeys and chimpanzees. Toxicol. Appl. Pharmacol. 1992; 114: 277
   PubMed Web of Science ®Google Scholar
• Medinsky M. A., Sabourin P., Lucier G., Birnbaum L. S., Henderson R. F. A physiological model for simulation of benzene metabolism by rats and mice. Toxicol. Appl Pharmacol. 1989; 99: 193
   PubMed Web of Science ®Google Scholar
• Travis C., Quillen J., Arms A. D. Pharmacokinetics of benzene. Toxicol. Appl. Pharmacol. 1990; 102: 400
   PubMed Web of Science ®Google Scholar
• Beliles R. P., Totman L. C. Pharmacokinetically based risk assessment of workplace exposure to benzene. Regul. Toxicol. Pharmacol. 1989; 9: 186
   PubMed Web of Science ®Google Scholar
• Bois F. Y., Smith M. T., Spear R. C. Mechanisms of benzene carcinogenesis. Application of a physiological model of benzene pharmacokinetics and metabolism. Toxicol. Lett. 1991; 56: 283
   PubMed Web of Science ®Google Scholar
• Spear R. C., Bois F. Y., Woodruff T., Auslander D., Parker J., Selvin S. Modeling benzene pharmacokinetics across three sets of animal data. Parametric sensitivity and risk implications. Risk Anal. 1991; 11: 641
   PubMed Web of Science ®Google Scholar
• Cox L. A., Ricci P. F. Reassessing benzene cancer risks using internal doses. Risk Anal. 1992; 12: 401
   PubMed Web of Science ®Google Scholar
• Scheding S., Loeffler M., Schmitz S., Seidel H. J., Wichmann H. E. Hematotoxic effects of benzene analyzed by mathematical modeling. Toxicology 1992; 72: 265
   PubMed Web of Science ®Google Scholar
• Cronkite E. P., Drew R. T., Inoue T., Hirayabashi Y., Bullis J. E. Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect. 1988; 82: 97
   Web of Science ®Google Scholar
• Green J. D., Snyder C., Lobue J., Goldstein B. D., Albert R. E. Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow and spleen cells of CD-1 male mice. Toxicol. Appl. Pharmacol. 1981; 159: 204
   Google Scholar
• Dean B. J. Recent findings on the genetic toxicology of benzene, toluene, xylenes, and phenols. Mutat. Res. 1985; 154: 153
   PubMed Web of Science ®Google Scholar
• Eastmond D. A. Induction of micronucleus and aneuploidy by the quinone-forming agents benzene ando-phenylphenol. Toxicol. Lett. 1993; 67: 105
   PubMed Web of Science ®Google Scholar
• Pollini G., Colombi R. II danno cromosomico midollare nell'anemia aplastica benzolica. Med. J. Lav. 1964; 55: 241
   Google Scholar
• Pollini G., Colombi R. Chromosomal damage in lymphocytes during benzene hemopathy. Med. J. Lav. 1964; 55: 641
   Google Scholar
• Forni A., Moreo L. Cytogenetic studies in a case of benzene leukemia. Eur. J. Cancer 1967; 3: 251
   PubMedGoogle Scholar
• Forni A., Moreo L. Chromosome studies in a case of benzene-induced erythroleukemia. Eur. J. Cancer 1969; 5: 459
   PubMed Web of Science ®Google Scholar
• Forni A., Pacifico E., Limonta A. Chromosome studies in workers exposed to benzene or toluene or both. Arch. Environ. Health 1971; 22: 373
   PubMed Web of Science ®Google Scholar
• Forni A., Cappellini A., Pacifico E., Vagliani E. Chromosome changes and their evolution with past exposure to benzene. Arch. Environ. Health 1971; 23: 385
   PubMed Web of Science ®Google Scholar
• Hartwich G., Schwanitz G., Becker J. Chromosomen aberrationen bei einen benzol-leukamie. Dtsch. Med. Wochenschr. 1969; 94: 1228
   PubMedGoogle Scholar
• Tough I. M., Smith P. G., Court Brown W. M., Harnden D. G. Chromosome studies on workers exposed to atmospheric benzene. The possible influence of age. Eur. J. Cancer 1970; 6: 49
   PubMed Web of Science ®Google Scholar
• Sellyei M., Kelemen E. Chromosome study in a case of granulocytic leukemia with “pelgerisation” 7 years after benzene pancytopenia. Eur. J. Cancer 1971; 7: 83
   Web of Science ®Google Scholar
• Erdogan G., Aksoy M. Cytogenetic studies in thirteen patients with pancytopenia and leukemia associated with long-term exposure to benzene. N. Istanbul Contrib. Clin. Sci. 1973; 10: 230
   PubMedGoogle Scholar
• Kahn H., Kahn M. H. Cytogenetic studies following chronic exposure to benzene. Arch. Toxicol. 1973; 31: 39
   Google Scholar
• Picciano D. Cytogenetic studies of workers exposed to benzene. Environ. Res. 1979; 19: 33
   PubMed Web of Science ®Google Scholar
• Sasiadek M. Non-random distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ. Health Perspect. 1992; 97: 255
   PubMed Web of Science ®Google Scholar
• Rothman N., Haas R., Hayes R. B., Yin S.-N., Wiemls J., Campelman S., Compton-Qintana P. J. E., Dosemeci M., Wang Y. Z., Li G.-L., Blot W., Smith M. T. Hematotoxicity and glycophorin A mutation frequency in workers exposed to benzene. Proc. Am. Assoc. Cancer Res. 1994; 35: 286
   Google Scholar
• Le Beau M. M., Larson R. A. Cytogenetics and neoplasia. Hematology Basic Principles and Practice, R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, H. J. Cohen. Churchill Livingstone, New York 1991; 638
   Google Scholar
• van den Berghe H., Louwagie A., Broechaert-van Orshoven A., David G., Verwilhen R. Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene. Blood 1979; 53: 558
   PubMed Web of Science ®Google Scholar
• Kissling M., Speck B. Chromosome aberrations in experimental benzene intoxication. Helv. Med. Acta 1971; 36: 59
   PubMedGoogle Scholar
• Siou G., Conan L., el Haitem M. Evaluation of the clastogenic action of benzene by oral administration with 2 cytogenetic techniques in mouse and Chinese hamster. Mutat. Res. 1981; 90: 273
   PubMed Web of Science ®Google Scholar
• Styles J. A., Richardson C. R. Cytogenetic effects of benzene. Dosimetric studies on rats exposed to benzene vapour. Mutat. Res. 1984; 135: 203
   PubMed Web of Science ®Google Scholar
• Fujie K., Ito Y., Maeda S. Acute cytogenetic effect of benzene on rat bone marrow cellsin vivo and the effect of inducers or inhibitors of drug-metabolizing enzymes. Mutat. Res. 1992; 298: 81
   PubMedGoogle Scholar
• Tunek A., Hogstedt G., Olofsson T. Mechanism of benzene toxicity. Effects of benzene and benzene metabolites on bone marrow cellularity, number of granulopoietic stem cells and frequency of micronuclei in mice. Chem. Biol. Interact. 1982; 39: 129
   PubMed Web of Science ®Google Scholar
• Hite M., Pecharo M., Smith I., Thornton S. The effect of benzene in micronucleus test. Mutat. Res. 1980; 77: 149
   PubMedGoogle Scholar
• Choy W. N., MacGregor J. T., Shelby M. D., Maronpot R. R. Induction of micronuclei by benzene in B6C3F1 mice. Retrospective analysis of blood smears from NTP carcinogenesis bioassay. Mutat. Res. 1985; 143: 55
   PubMedGoogle Scholar
• Gad-El Karim M. M., Ramanujam S., Legator M. S. Correlation between the induction of micronuclei in bone marrow by benzene exposure and the excretion of metabolites in the urine by CD-1 mice. Toxicol. Appl. Pharmacol. 1986; 85: 464
   PubMed Web of Science ®Google Scholar
• Anwar W. A., Au W. W., Legator M., Sadagopa R. V. M. Effect of dimethyl sulfoxide on the genotoxicity and metabolism of benzene in vivo. Carcinogenesis 1989; 10: 441
   PubMed Web of Science ®Google Scholar
• Harper B. L., Ramanujam V. M. S., Gad-El-Karim M. M., Legator M. S. The influence of simple aromatics on benzene clastogenicity. Mutat. Res. 1984; 128: 105
   PubMed Web of Science ®Google Scholar
• Ciranni R., Barale R., Marrazzini A., Loprieno N. Benzene and the genotoxicity of its metabolites. I. Transplacental activity in mouse fetuses and in their dams. Mutat. Res. 1988; 208: 61
   PubMed Web of Science ®Google Scholar
• Ciranni R., Barale R., Ghelardini G., Loprieno N. Benzene and the genotoxicity of its metabolites. II. The effect of the route of administration on the micronuclei and bone marrow depression in mouse bone marrow cells. Mutat. Res. 1988; 209: 23
   PubMed Web of Science ®Google Scholar
• Adler I.-D., Kliesch U. Comparison of single and multiple treatment regimens in the mouse bone marrow micronucleus assay for hydroquinone, HQ and cyclophosphamide, CP. Mutat. Res. 1990; 234: 115
   PubMedGoogle Scholar
• Pirozzi S. J., Renz J. F., Kalf G. F. The prevention of benzene-induced genotoxicity in mice by indomethacin. Mutat. Res. 1989; 222: 291
   PubMed Web of Science ®Google Scholar
• Tice R. R., Costa D. L., Drew R. T. Cytogenetic effects of inhaled benzene in murine bone marrow, induction of sister chromatid exchanges, chromosomal aberrations, and cellular proliferation inhibition in DBA/2 mice. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 2148
   PubMed Web of Science ®Google Scholar
• Morimoto K., Wolff S. Increase in sister chromatid exchanges and perturbations of cell division kinetics in human lymphocytes by benzene metabolites. Cancer Res. 1980; 40: 1189
   PubMed Web of Science ®Google Scholar
• Morimoto K. Induction of sister chromatid exchanges and cell division delays in human lymphocytes by microsomal activation of benzene. Cancer Res. 1983; 43: 1330
   PubMed Web of Science ®Google Scholar
• Morimoto K., Wolff S., Koizumi A. Induction of sister chromatid exchanges in human lymphocytes by microsomal activation of benzene metabolites. Mutat. Res. 1983; 119: 355
   PubMed Web of Science ®Google Scholar
• Erexson G. L., Wilmer J. L., Kligerman A. D. Sister chromatid exchange induction in human lymphocytes exposed to benzene and its metabolites in vitro. Cancer Res. 1985; 45: 2471
   PubMed Web of Science ®Google Scholar
• Witz G., Gad S. C., Tice R. R., Oshiro Y., Piper C. E., Goldstein B. D. Genetic toxicity of the benzene metabolitetrans, trans-muconaldehyde in mammalian and bacterial cells. Mutat. Res. 1990; 240: 295
   PubMed Web of Science ®Google Scholar
• McCarroll N. E., Piper C. E., Keech B. H. Bacterial microsuspension assays with benzene and other organic solvents. Environ. Mutagen. 1980; 2: 281
   Google Scholar
• Jacobs R. H., Cornbleet M. A., Vardiman J. W., et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1765; 67: 1986
   Google Scholar
• Gold E. J., Conjalka M., Pelus L. M., et al. Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights into pathophysiology and prognosis. J. Clin. Oncol. 1983; 1: 627
   PubMed Web of Science ®Google Scholar
• Third MIC Cooperative Study Group (1987). Morphologic, immunologic, and cytogenetic (MIC) working classification of the primary myelodysplastic syndromes and therapy-related myelodysplasias and leukemias. Cancer Genet. Cytogenet. 1988; 32: 1
   PubMedGoogle Scholar
• Mitelman F., Brandt L., Nilsson P. G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 1978; 52: 1229
   PubMed Web of Science ®Google Scholar
• Mitelman G., Nilsson P. G., Brandt L., et al. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 1981; 4: 197
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Alimena G., Rowley J. D., et al. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 1982; 60: 404
   PubMed Web of Science ®Google Scholar
• Sasiadek M. Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ. Health Perspect. 1992; 97: 255
   PubMed Web of Science ®Google Scholar
• Aksoy M. Leukemia in workers due to occupational exposure to benzene. N. Istanbul Contrib. Clin. Sci. 1977; 12: 3
   PubMedGoogle Scholar
• Koeffler H. F., Rowley J. D. Therapy-related acute nonlymphocytic leukemia. Neoplastic Diseases of the Blood, P. H. Wiernik, G. P. Canelloe, R. A. Kyle, C. A. Schiffer. Churchill Livingstone, New York 1984; 357
   Google Scholar
• Rowley J. D., Golomb H. M., Vardiman J. W. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndrome in patients with previously treated malignant disease. Blood 1981; 58: 759
   PubMed Web of Science ®Google Scholar
• DeBraekeleer M., Lin C. C. 4;11 Translocation-associated acute leukemia: a comprehensive analysis. Cancer Genet. Cytogenet. 1986; 21: 53
   PubMedGoogle Scholar
• Sole F., Caballin M. R., Coll M. D., Woessner S., Egozcue J. Acute lymphoblastic leukemia with t(4;11) in a patient previously exposed to a carcinogen. Cancer Genet. Cytogenet. 1990; 49: 133
   PubMedGoogle Scholar
• Miazzo M., Sozzi G., Castellano M., Calderone C., Orazi A., Pierotti M. A., Viviani S., Delia Porta G. Cytogenetic study of 14 patients therapy-related nonlymphocytic leukemia (t-ANLL) and myelodysplastic syndromes (t-MDS). Book of Abstracts of the 21st European Society of Human Genetics, GroningenThe Netherlands. 48
   Google Scholar
• Le Beau M. M., Albain K. S., Larson R. A., et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute non-lymphocytic leukemia. Further evidence for characteristic abnormalities of chromosomes Nos. 5 and 7. J. Clin. Oncol. 1986; 4: 325
   PubMed Web of Science ®Google Scholar
• Groopman J. E., Molina J.-M., Scadden D. T. Hematopoietic growth factors: biology and clinical applications. N. Engl. J. Med. 1989; 321: 1449
   PubMed Web of Science ®Google Scholar
• Willman C. L., Sever C., Pallavicini M., Harada H., Tanaka N., Slovak M., Yamamoto H., Harada K., Meeker T. C., List A., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968
   PubMed Web of Science ®Google Scholar
• Harada H., Kitagawa M., Tanaka B., Yamamoto H., Harada K., Ishihara M., Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993; 259: 971
   PubMed Web of Science ®Google Scholar
• Goyert S. M., Ferraro R., Rettig W. J., et al. The CD 14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497
   PubMed Web of Science ®Google Scholar
• Sukhatme V. P., Cao X., Chang L. D., et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation and after cellular depolarization. Cell 1988; 53: 37
   PubMed Web of Science ®Google Scholar
• Kere J., Ruutu T., Lahtimen R., de la Chapelle A. Molecular characterization of chromosome 7 long arm abnormalities in myeloid disorders. Blood 1987; 70: 1349
   PubMed Web of Science ®Google Scholar
• Shannon K. M., Turham A. G., Chang S. S. Y., et al. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7. J. Clin. Invest. 1989; 84: 984
   PubMed Web of Science ®Google Scholar
• Tenth International Workshop on Human Gene Mapping. Human gene mapping 10. Cytogenet. Cell Genet. 1989; 51: 1
   Google Scholar
• Ludwig L., Schultz A. S., Janssen J. W., Grunewald K., Bertram C. R. p53 Mutations in the myelodysplastic syndromes. Leukemia 1992; 6: 1302
   PubMed Web of Science ®Google Scholar
• Jonveaux P., Fenaux P., Quiqandon I., Pignon J. M., Lai J., Loucheaux-Lefebvre M. H., Goossens M., Bauters F., Berger R. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene 1991; 6: 2234
   Web of Science ®Google Scholar
• Slingerland J. M., Minden M., Benchimoi S. Mutations in the p53 gene in acute myelogenous leukemia. Blood 1991; 77: 1500
   PubMed Web of Science ®Google Scholar
• Fenaux P., Preudhomme C., Quiquandon J., Jonveaux P., Lai J. I., Vanrumbke M., Loucheux-Lefbvre M. H., Bauter F., Berger R., Kerckaert J. P. Mutations of the p53 gene in acute myeloid leukemia. Br. J. Haematol. 1992; 80: 178
   PubMed Web of Science ®Google Scholar
• Ganser A., Seipelt G., Lindemann A., Ottmann I. G., Galk S., Eder M., Herrmann F., Becher R., Hoffken K., Buchner T., Klausmann M., Frisch J., Schultz G., Mertelsman R., Hoelzer D. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 1990; 76: 455
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558
   PubMed Web of Science ®Google Scholar
• Longo L., Pandolfi P. P., Biondi A., Rambaldi A., Mencarelli A., LoCoco F., Diverio D., Pagoraro L., Avanzi G., Tabilio A., Zangrilli D., Alcalay M., Donti E., Grignani F., Pelicci P. G. Rearrangements and aberrant expression of the RARα gene in acute promyelocytic leukemias. J. Exp. Med. 1990; 172: 1571
   PubMed Web of Science ®Google Scholar
• Evans R. M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889
   PubMed Web of Science ®Google Scholar
• Meng-Er H., Yu-Chen T., Shu-Rong C., Jin-Ren C., Jia-Xiang L., Long-Jun G., Zhen-Yi W. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Collins S. J., Keene B. R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000
   PubMed Web of Science ®Google Scholar
• Lewin B. Oncogenic conversion by regulatory changes in transcription factors. Cell 1991; 64: 303
   PubMed Web of Science ®Google Scholar
• Metcalf D., Nowell P. C., Rowley J. D., Sachs L. Chromosomal and growth factor abnormalities in leukemia. Cancer Res. 1991; 51: 2494
   PubMed Web of Science ®Google Scholar
• Rowley J. D., Testa J. R. Chromosome abnormalities in malignant hematologic diseases. Adv. Cancer Res. 1982; 36: 103
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M L. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 10, 431
   Web of Science ®Google Scholar
• Berger R., Bernheim A., Flandrin G. Absence d'anomalie chromosomique et leucemie aigue. C. R. Acad. Sci. III 1980; 290: 1557
   Google Scholar
• Dubreuil P., Torres H., Courcoul M.-A., Birg F., Mannoni P. c-fms expression is a molecular marker of human acute myeloid leukemias. Blood 1988; 72: 1081
   PubMed Web of Science ®Google Scholar
• Tobal K., Pagliuca A., Bhatt B., Bailey N., Layton D. M., Mufti G. J. Mutation of the human fms gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1990; 4: 486
   PubMed Web of Science ®Google Scholar
• Ridge S. A., Worwood M., Oscier D., Jacobs A., Padua R. A. FMS mutations in myelodysplasia, leukemia and normal subjects. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 1377
   PubMed Web of Science ®Google Scholar
• Bartram C. R. Mutations inras genes in myelocytic leukemias and myelodysplastic syndromes. Blood Cells 1988; 14: 533
   PubMedGoogle Scholar
• Bos J. L., Toksoz D., Marshall C. J., et al. Amino-acid substitutions at codon 13 of theN-ras oncogene in human acute myeloid leukemia. Nature 1985; 315: 726
   PubMed Web of Science ®Google Scholar
• Hirai H., Okada M., Mizoguchi H., et al. Relationship between an activatedN-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome. Blood 1988; 71: 256
   PubMed Web of Science ®Google Scholar
• Edison L., Brian H., Rodman M., et al. The role of mutantras genes in preleukemic states. Blood 1987; 70(Suppl.)282a
   PubMedGoogle Scholar
• Bashey A., Gill R., Levi C. J., Farr R., Clutterbuck J. L., Millar J. L., Pragnell I. B., Marshall C. J. Mutational activation of theN-ras oncogene assessed in primary clonogenic cultures of acute myeloid leukemia (AML): implications for the role ofN-ras mutation in AML pathogenesis. Blood 1992; 79: 981
   PubMed Web of Science ®Google Scholar
• Taylor J. A., Sandler D. P., Bloomfield C. D., Shore D. L., Ball E. D., Neubauer A., McIntyre O. R., Liu E. ras oncogene activation and occupational exposures in acute myeloid leukemia. J. Natl. Cancer Inst. 1992; 84: 1626
   PubMed Web of Science ®Google Scholar
• Morishita K., Paraganas E., William C. L., Whittaker M. H., Drabkin H., Oval J., Taetle R., Valentine M. B., Ihle J. N. Activation ofEvi-1 gene expression in human acute myelogenous leuke-mias by translocations spanning 300 to 400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 3937
   PubMed Web of Science ®Google Scholar
• Blatt C., Aberdam D., Schwartz R., Sacks L. DNA rearrangement of a homeobox gene in myeloid leukemia cells. EMBO J. 1988; 7: 4283
   PubMed Web of Science ®Google Scholar
• Perkins A., Kongsuwan K., Visvader J., Adams J. M., Cory S. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 8398
   PubMed Web of Science ®Google Scholar
• Frash V. N., Yushkov B. G., Karaulov A. V., Skuratov V. Mechanism of action of benzene on hematopoiesis. Investigation of hematopoietic stem cells. Bull. Exp. Biol. Med. 1976; 82: 985
   Web of Science ®Google Scholar
• Speck B., Cornu P., Nissen C., Groff P., Weber W., Jeannet M. On the pathogenesis and treatment of aplastic anemia. Experimental Hematology Today, S. J. Baum, G. D. Ledney. Springer-Verlag, New York 1978; 43
   Google Scholar
• Cronkite E. P., Inoue T., Carsten A. L., Miller M. E., Bullis J. E., et al. Effects of benzene inhalation on murine pleuripotential stem cells. J. Toxicol. Environ. Health 1982; 9: 411
   PubMed Web of Science ®Google Scholar
• Keller K. A., Snyder C. A. Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells. Toxicology 1986; 42: 171
   PubMed Web of Science ®Google Scholar
• Keller K. A., Snyder C. A. Mice exposed in utero to 20 ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure. Fundam. Appl. Toxicol. 1988; 10: 224
   PubMedGoogle Scholar
• Tunek A., Olofsson T., Berlin M. Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Toxicol. Appl. Pharmacol. 1981; 59: 149
   PubMed Web of Science ®Google Scholar
• Dempster A. M., Snyder C. A. Effect of low-level benzene exposure on murine hemopoietic precursor cells. Toxicologist 1986; 6: 285
   Google Scholar
• Pirozzi S. J., Schlosser M. J., Kalf G. F. Prevention of benzene-induced myelotoxicity and prostaglandin synthesis in bone marrow of mice by inhibitors of prostaglandin H synthase. Immunopharmacology 1989; 18: 39
   PubMedGoogle Scholar
• Seidel H., Barthel E., Zinser D. The hematopoietic stem cell compartments in mice during and after long term inhalation of three doses of benzene. Exp. Hematol. 1989; 17: 300
   PubMed Web of Science ®Google Scholar
• Dempster A. M., Snyder C. A. Short-term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch. Toxicol. 1990; 64: 539
   PubMed Web of Science ®Google Scholar
• Kalf G. F., O'Connor A. The effects of benzene and hydroquinone on myeloid differentiation of HL-60 promyelocytic leukemia cells. Leuk. Lymph. 1993; 11: 331
   PubMed Web of Science ®Google Scholar
• Fontana J. A., Colbert D. A., Deisseroth A. B. Identification of a population of bipotent stem cells in the HL-60 human promyelocytic leukemia cell line. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 3838
   Web of Science ®Google Scholar
• Collins S. J. The HL-60 promyelocytic leukemia cell line. Proliferation differentiation and oncogene expression. Blood 1987; 70: 1233
   PubMed Web of Science ®Google Scholar
• Rovera G., Santoli D., Damsky G. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diesters. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 2779
   PubMed Web of Science ®Google Scholar
• Huberman E., Callahan M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor promoting agents. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 1293
   PubMed Web of Science ®Google Scholar
• Murao S., Gemmell M. A., Callahan M. F., Anderson N. L., Huberman E. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1α, 25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Cancer Res. 1983; 43: 4989
   PubMed Web of Science ®Google Scholar
• Tanaka H., Abe E., Miyaura C., Shiina Y., Suda T. 1α,25-Dihydroxyvitamin D3 induces differentiation of human promyelocytic cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem. Biophys. Res. Commun. 1983; 117: 86
   PubMed Web of Science ®Google Scholar
• McCarthy D. M., San Miguel J. F., Freake H. C., Green P. M., Zola H., Catovsky D., Goldman J. M. 1α,25-Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukemia (HL-60) cells and induces monocyte-macrophages in HL-60. Leuk. Res. 1983; 7: 51
   PubMed Web of Science ®Google Scholar
• Breitman J. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic cell line HL-60 by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 2936
   PubMed Web of Science ®Google Scholar
• Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide (DMSO) and other polar solvents. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 2458
   PubMed Web of Science ®Google Scholar
• Valtieri M., Tweardy J., Caracciolo D., Johnson K., Mavilio F., Altmann S., Santoli D., Rovera G. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 1987; 138: 3829
   PubMed Web of Science ®Google Scholar
• Irons R. D., Stillman W. S., Colagiovanni D. B., Henry V. A. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 3691
   PubMed Web of Science ®Google Scholar
• Oliveira N. L., Kalf G. F. Induced differentiation of HL-60 promyelocytic leukemia cells to monocyte/macrophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene. Blood 1992; 79: 627
   PubMed Web of Science ®Google Scholar
• Tavassoli M., Friedenstein A. Hemopoietic stromal microenvironment. Am. J. Hematol. 1983; 15: 195
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell Physiol. 1977; 91: 335
   PubMed Web of Science ®Google Scholar
• Dexter T. M. Hemopoiesis in long-term bone marrow cultures. Acta Haematol. 1979; 62: 299
   PubMed Web of Science ®Google Scholar
• Garnett H., Cronkite E. P., Drew R. T. Effect of in vivo exposure to benzene on the characteristics of bone marrow adherent cells. Leuk. Res. 1983; 7: 803
   PubMed Web of Science ®Google Scholar
• Chertkov J. L., Lutton J. D., Jiang S., daSilva J.-L., Abraham N. G. Hematopoietic effects of benzene inhalation assessed by murine long-term bone marrow culture. J. Lab. Clin. Med. 1992; 119: 412
   PubMed Web of Science ®Google Scholar
• Gaido K. W., Wierda D. In vitro effects of benzene metabolites on mouse bone marrow stromal cells. Toxicol. Appl. Pharmacol. 1984; 76: 45
   PubMed Web of Science ®Google Scholar
• Gaido K. W., Wierda D. Modulation of stromal cell function in DBA/2 and B6C3F1 mice exposed to benzene or phenol. Toxicol. Appl. Pharmacol. 1985; 81: 469
   PubMed Web of Science ®Google Scholar
• Gaido K. W., Wierda D. Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin. Toxicol. Appl. Pharmacol. 1987; 89: 378
   PubMed Web of Science ®Google Scholar
• MacEachern L., Synder R., Laskin D. L. Alterations in the morphology and functional activity of bone marrow phagocytes following benzene treatment of mice. Toxicol. Appl. Pharmacol. 1992; 117: 147
   PubMed Web of Science ®Google Scholar
• Thomas D. J., Reasor M. J., Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol. Appl. Pharmacol. 1989; 97: 440
   PubMed Web of Science ®Google Scholar
• Thomas D. J., Sadler A., Subrahmanyam V. V., Siegel D., Reasor M. J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone. Comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 1990; 37: 255
   PubMed Web of Science ®Google Scholar
• Renz J. F., Kalf G. F. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity. Inhibition of conversion of pre-IL-1α to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematoxicity in mice by IL-1α. Blood 1991; 78: 938
   PubMed Web of Science ®Google Scholar
• Moore M. A. S. Regulatory role of the macrophage in hemopoiesis. Stem Cells and Tissue Homeostasis, B. I. Lord, C. S. Potten, R. J. Cole. Cambridge University Press, London 1978; 187
   Google Scholar
• Post G. B., Snyder R., Kalf G. F. Metabolism of benzene and phenol in macrophagesin vitro and the inhibition of RNA synthesis by benzene metabolites. Cell Biol. Toxicol. 1986; 2: 231
   PubMed Web of Science ®Google Scholar
• Ido M., Harada M., Furuichi H., Matsuoka N., Nakano K., Sohmura Y. Interleukin-1-induced sequential myelorestoration. Dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice. Exp. Hematol. 1992; 20: 161
   PubMed Web of Science ®Google Scholar
• Gascon P., Scala G. Decreased interleukin-1 production in aplastic anemia. JAMA 1988; 85: 668
   PubMed Web of Science ®Google Scholar
• Nakao N., Matsushima K., Yoiung N. Decreased interleukin-1 production in aplastic anemia. Br. J. Haematol. 1989; 71: 431
   PubMed Web of Science ®Google Scholar
• Katayama N., Nishikawa M., Minami N., Shirakawa S. Putative involvement of protein kinase c in proliferation of human myeloid progenitor cells. Blood 1989; 73: 123
   PubMed Web of Science ®Google Scholar
• Whetton A. D., Heyworth C. M., Dexter T. M. Phorbol esters activate protein kinase c and glucose transport and can replace the requirement for growth factor in interleukin-3-dependent multipotent stem cells. J. Cell Sci. 1986; 84: 93
   PubMed Web of Science ®Google Scholar
• Weinstein I. B. Nonmutagenic mechanisms in carcinogenesis. Role of protein kinase c in signal transduction and growth control. Environ. Health Perspect. 1991; 93: 175
   PubMed Web of Science ®Google Scholar
• Hsiao W.-L. W., Housey G. M., Johnson M. D., Weinstein I. B. Cells that overproduce protein kinase c are more susceptible to transformation by an activatedH-ras oncogene. Mol. Cell. Biol. 1989; 9: 2641
   PubMed Web of Science ®Google Scholar
• Housey G. M., Johnson M. D., Hsiao W.-L. W., O'Brian C. A., Murphy J. P., Kirschmeier P., Weinstein I. B. Overproduction of protein kinase c causes disordered growth control in rat fibroblasts. Cell 1988; 52: 343
   PubMed Web of Science ®Google Scholar
• Krauss R. S., Housey G. M., Johnson M. D., Weinstein I. B. Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase c. Oncogene 1989; 4: 991
   PubMed Web of Science ®Google Scholar
• Yarden Y., Kuang W. J., Yang F. T., Coussens L., Munemitsu S., Dull T. J., Chen E., Schlessinger L. J., Francke U., Ullrich A. Human photo-oncogenec-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987; 6: 3341
   PubMed Web of Science ®Google Scholar
• Huang E., Nocka K., Beier D. R., Chu T. Y., Buck J., Lahm H. W., Wellner D., Leder P., Besmer P. The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of thec-kit receptor, the gene product of the W locus. Cell 1990; 63: 225
   PubMed Web of Science ®Google Scholar
• Witte O. N. Steel locus defines new multipotent growth factor. Cell 1990; 63: 5
   PubMed Web of Science ®Google Scholar
• Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonezawa T., Tarui S., Griffin J. Expression and functional role of the proto-oncogenec-kit in acute myeloblasts leukemia. Blood 1991; 78: 2962
   PubMed Web of Science ®Google Scholar
• Cheng K. C., Cahill D. S., Kasai H., Nishimura S., Loeb L. 8-OH Deoxyguanosine, an abundant form of oxidative DNA damage causes G-T and A-C substitutions. J. Biol. Chem. 1992; 267: 167
   Web of Science ®Google Scholar
• Fenaux P., Jonveaux P., Quiquandon I., Lai J. L., Pignon J. M., Loucheux-Lefebvre M. H., Bauters F., Berger R., Kerckaert J. P. p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652
   PubMed Web of Science ®Google Scholar
• Fenaux P., Preudhomme C., Quiquandon I., Jonveaux P., Lai J. L., Vanrumbeke M., Loucheux-Lefebvre M. H., Bauters F., Berger R., Kerckaert J. P. Mutations of the p53 gene in acute myeloid leukemia. Br. J. Haematol. 1992; 80: 178
   PubMed Web of Science ®Google Scholar
• Irons R. D., Neptun D. A. Effects of the principal hydroxymetabolites of benzene on microtubule polymerization. Arch. Toxicol. 1980; 45: 297
   PubMed Web of Science ®Google Scholar
• Irons R. D., Neptun D. A., Pfeiffer R. W. Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene. Evidence for a common mechanism. J. Reticuloendothelial. Soc. 1981; 30: 359
   PubMedGoogle Scholar
• Bernal S. D., Chen L. B. Induction of cytoskeleton-associated proteins during differentiation of human myeloid leukemic cell lines. Cancer Res. 1982; 42: 5106
   PubMed Web of Science ®Google Scholar
• Bernal S. D., Stahel R. A. Cytoskeleton-associated proteins. Their role as cellular integrators in neoplastic processes. Crit. Rev. Oncol. Hematol. 1985; 3: 191
   PubMed Web of Science ®Google Scholar
• Brown W. J., Norwood C. F., Smith R. G., Snell W. J. Development of capping ability during differentiation of HL-60 human promyelocytic leukemia cells. J. Cell Physiol. 1981; 106: 127
   PubMed Web of Science ®Google Scholar
• Leung M., Sokoloski J. A., Sartorelli A. C. Changes in microtubules, microtubule-associated proteins and intermediate filaments during the differentiation of HL-60 leukemia cells. Cancer Res. 1992; 52: 949
   PubMed Web of Science ®Google Scholar
• Leung M., Sartorelli A. C. The effects of microtubule disrupting drugs on the differentiation of HL-60 leukemia cells. Leukemia Res. 1992; 16: 929
   PubMed Web of Science ®Google Scholar
• Miller A. M., Weiner R. S., Ziboh V. A. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp. Hematol. 1986; 14: 760
   PubMed Web of Science ®Google Scholar
• Ziboh V. A., Wong T., Wu M. C., Yunis A. A. Modulation of colony stimulating factor-induced murine myeloid colony formation byS-peptidolipoxygenase products. Cancer Res. 1986; 46: 600
   PubMed Web of Science ®Google Scholar
• Snyder D. S., Castro R., Desforges J. F. 5-Lipoxygenase metabolites of arachidonic acid modulate proliferation of malignant hematopoietic cell lines. Blood 1986; 70: 185a
   Google Scholar
• Miller A. M., Cullen M. K., Kobb S. M., Weiner R. S. Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J. Lab. Clin. Med. 1989; 113: 355
   PubMed Web of Science ®Google Scholar
• Jensen P. K. A., Junien C., Despoisse S., et al. Inverted tandem duplication of the short arm of chromosome 8. A non-random de novo structural aberration in man. Localization of the gene for glutathionine reductase in subband 8p21.1. Ann. Genet. 1982; 25: 207
   PubMedGoogle Scholar
• Silverstein D. L., Shows T. B. Gene for glutathioneS-transferase-1 (GST1) is on human chromosome 11. Somatic Cell Genet. 1982; 8: 667
   PubMedGoogle Scholar
• Rowley J. D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 1984; 44: 3159
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for colon tumorigenesis. Cell 1990; 61: 759
   PubMed Web of Science ®Google Scholar